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INTRODUCTION 
Polypharmacy is the concurrent use of multiple 
medications, often defined as the use of five or more 
medications on routinely basis1 which includes use of 
over the counter drugs, prescribed, traditional and 
complementary medicines by a patient.2 The term 
polypharmacy was first mentioned in the medical 
literature more than 150 years ago3 but still a majority 
of the population, including healthcare professionals 
have no idea about it. In most instances, 
polypharmacy is a logical response for management 
of complex and co-existing health problems in 
elderly.4 However, most of the old people are using 
lot many medications in an improper way which is of 
growing concern. Combination of multiple drugs can 
make their harmful effects outweigh the benefits 
when used in a complex regimen commonly seen in 
patients admitted to nursing homes, among elderly 
people and in the context of EOLC, end of life care.5-7  
 
Medicines are often used in inappropriate ways that 
undermine their value. They are being prescribed for 
unapproved indications, not prescribed when they 
should be and patients often take them incorrectly, 
show treatment non-compliance or combine these 
drugs with other herbal products or supplements and 
this can cause potential harm.  
 
Polypharmacy is not only a burden for patients, it can 
be very dangerous leading to medically significant 
issues. It is vitally important that patients are 
authorized to make informed choices regarding the 
medications they are taking, and healthcare 
professionals  play   a   prime   role   in educating   the  
 
 
patients. The factors like boom in pharmaceutical 
research and development to bring into the market 
the treatments for common chronic diseases, the 
willingness of patients to consume them, policies of 
governments and society to pay for them has given 
rise to the prevalence of polypharmacy. 
 
Problems associated with polypharmacy are more 
prevalent in the elderly because of countless 
contributing factors like deterioration of general 
health with age, limited daily activities, reduced 
mobility, increased multimorbidity that is associated 
with multiple symptoms, impairments and 
disabilities, poor compliance due to complex and 
multiple drug therapies and these issues can interfere 
with the treatment process, lead to exacerbation of 
underlying disease and in turn can increase the need 
for more medication.8,9  
 
The patient groups that are most vulnerable to the 
risks of polypharmacy are susceptible to events such 
as drug interactions, higher risk of falls, fractures, 
chronic obstructive pulmonary disease, urinary 
retention, bleeding, renal  injury and failure, physical 
and cognitive impairment, disability, progression of 
underlying diseases, non-adherence, poor nutritional 
status, frailty, sarcopenia, hampered quality of life 
more hospital admissions and even death. 
 
If the medicines are prescribed for the purpose of 
achieving specific therapeutic benefits with an 
informed consent and agreement of the motivated 
patient   to    take   these   as intended, and have been 
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regulated to curtail the risk of drug related side 
effects and reactions and therapeutic objectives are 
being met or there is a probability of the same being 
achieved in the time ahead, the polypharmacy can be 
considered as appropriate. 
 
Use of one or more medicines that are no longer 
required, either because there is no confirmed 
diagnosis, the indication has resolved, the prescribed 
dose is unnecessarily high, the particular drug is 
contraindicated in the concerned population, the 
indication is not approved for that drug, there is no 
response or partial response to the drug, or the 
combination of prescribed drugs can result in 
interaction, cause adverse reaction, or the patient is 
not willing or able to take one or more medicines as 
intended due to any reason results in inappropriate 
polypharmacy. 
 
Polypharmacy can result from several risk factors, 
most of them are patient centered like co-existing 
medical conditions under the care of several 
specialists, medications for symptomatic relief, self-
medication, having chronic mental health conditions, 
prescription of medication to treat the adverse effects 
of another drug and residing in a long-term care 
facility like nursing homes. The factors at healthcare 
level includes incomplete medical records, 
inappropriate or wrong diagnosis, drug prescription 
and dosing errors, prescription of unnecessary 
medications, easy availability of diverse over the 
counter drugs, lack of patient motivation and 
provision of inadequate information to patients.  
 
Many tools have been formulated to identify 
potentially inappropriate medication use although no 
single one has been of much help in decreasing the 
risk of polypharmacy. These include the Beers, the 
Medication Appropriateness Index, screening tool of 
older people's prescriptions and screening tool to 
alert to right treatment criteria. Regular and 
thorough monitoring of the patients' active 
medication is a must. It is also advisable to 
deprescribe any unnecessary medications. This would 
eventually decrease the pill burden, minimize the 
risks of drug interaction and adverse drug reactions, 
and also reduce the financial burden. The physicians 
should use point of care documentation that would 
help in the deprescription process and also to make 
the    patients   understand   the    need   to    decrease  
 
 
medication overload in order to diminish the risks of 
polypharmacy.10 
 
A major potential cause of polypharmacy is low 
literacy rate in general or poor health literacy at 
individual or population level. Miscommunication or 
misunderstanding physician prescriptions or orders 
as a result of disabilities, cognitive dysfunction, 
mental impairment and mistaking drugs because of 
similarity in shape, size, name or color, are additional 
contributing factors which may arise more often in 
elderly people.8,9,11,12 
 
Polypharmacy is an unfortunate sequela of the 
development and advancement in the field of medical 
science and research. This unpleasant consequence 
has led to high cost of medical treatment and poor 
health outcomes. Life expectancy has increased with 
significant rise in old population. Every day, new 
medicines are being discovered and new drugs are 
being formulated in pharmaceutical machinery to 
treat infinite medical conditions. The bitterness lies 
in the fact that these drugs behave like a double-
edged sword. They are meant to upgrade, refine and 
boost patient health but they also have the capability 
and potential to result in adverse events, impairment 
and conditions that can be life-threatening or even 
fatal. Healthcare professionals need to be cautious 
and watchful in delivering treatment and care to their 
patients who are subjected to multiple medications 
and, when required, they should modify, alter or 
optimize the current regimen. They should also 
provide appropriate education regarding the drug 
use, dosage, adverse events and drug interaction to 
the patients and also perform a detailed and complete 
medication review with regular follow ups for 
subjects who are prescribed multiple medications. 
 
CONCLUSION 
The has been a tremendous increase in the 
prevalence of polypharmacy across the globe with 
most of the older population being exposed to 
polypharmacy which in turn is associated with a 
broad range of detrimental consequences. There is an 
urgent need to formulate, elaborate and refine the 
methods to assess the hazards of polypharmacy. 
There is also a need to review the international trends 
in the prevalence of polypharmacy, summarize and 
analyze their results and update the healthcare 
professionals   regarding    the   clinical  aftermaths of  
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polypharmacy. 
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